HighTower Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $3.75M | Sell |
95,301
-17,829
| -16% | -$770K | 0.37% | 45 |
|
|
2022
Q4 | $5.75M | Buy |
113,130
+405
| +0.4% | +$19.4K | 0.55% | 37 |
|
|
2022
Q3 | $4.93M | Buy |
112,725
+8,557
| +8% | +$416K | 0.54% | 38 |
|
|
2022
Q2 | $5.29K | Buy |
104,168
+1,241
| +1% | +$63.2K | 0.55% | 37 |
|
|
2022
Q1 | $5.33M | Buy |
102,927
+3,451
| +3% | +$179K | 0.51% | 37 |
|
|
2021
Q4 | $5.87M | Buy |
99,476
+472
| +0.5% | +$23.4K | 0.57% | 38 |
|
|
2021
Q3 | $4.26M | Sell |
99,004
-496
| -0.5% | -$22K | 0.52% | 41 |
|
|
2021
Q2 | $3.9M | Buy |
99,500
+23,199
| +30% | +$902K | 0.48% | 44 |
|
|
2021
Q1 | $2.76M | Buy |
76,301
+15,068
| +25% | +$535K | 0.37% | 54 |
|
|
2020
Q4 | $2.25M | Sell |
61,233
-7,786
| -11% | -$286K | 0.32% | 56 |
|
|
2020
Q3 | $2.4M | Sell |
69,019
-4,866
| -7% | -$171K | 0.38% | 53 |
|
|
2020
Q2 | $2.29M | Buy |
73,885
+28,243
| +62% | +$960K | 0.35% | 53 |
|
|
2020
Q1 | $1.41M | Sell |
45,642
-675
| -1% | -$23K | 0.25% | 60 |
|
|
2019
Q4 | $1.72M | Buy |
46,317
+5,481
| +13% | +$195K | 0.21% | 62 |
|
|
2019
Q3 | $1.39M | Sell |
40,836
-2,540
| -6% | -$92.4K | 0.18% | 65 |
|
|
2019
Q2 | $1.78M | Sell |
43,376
-112,976
| -72% | -$4.49M | 0.23% | 62 |
|
|
2019
Q1 | $6.3M | Sell |
156,352
-4,559
| -3% | -$183K | 0.81% | 27 |
|
|
2018
Q4 | $6.66M | Sell |
160,911
-72,722
| -31% | -$3.02M | 0.96% | 23 |
|
|
2018
Q3 | $9.77M | Hold |
233,633
| – | – | 1.09% | 24 |
|
|
2018
Q2 | $8.04M | Sell |
233,633
-2,619
| -1% | -$89.5K | 0.93% | 26 |
|
|
2018
Q1 | $7.96M | Sell |
236,252
-20,516
| -8% | -$705K | 0.98% | 25 |
|
|
2017
Q4 | $8.82M | Sell |
256,768
-1,702
| -0.7% | -$58K | 0.99% | 25 |
|
|
2017
Q3 | $8.76M | Sell |
258,470
-1,876
| -0.7% | -$60.3K | 1.05% | 25 |
|
|
2017
Q2 | $8.3M | Sell |
260,346
-4,462
| -2% | -$141K | 0.95% | 27 |
|
|
2017
Q1 | $8.59M | Sell |
264,808
-1,294
| -0.5% | -$40.8K | 0.98% | 24 |
|
|
2016
Q4 | $8.2M | Buy |
266,102
+10,097
| +4% | +$308K | 0.92% | 23 |
|
|
2016
Q3 | $8.23M | Buy |
256,005
+7,873
| +3% | +$263K | 0.92% | 21 |
|
|
2016
Q2 | $8.29M | Buy |
248,132
+7,386
| +3% | +$236K | 0.89% | 19 |
|
|
2016
Q1 | $6.77M | Buy |
240,746
+57,342
| +31% | +$1.64M | 0.85% | 20 |
|
|
2015
Q4 | $5.62M | Buy |
183,404
+119,112
| +185% | +$3.75M | 0.75% | 19 |
|
|
2015
Q3 | $1.92M | Buy |
64,292
+14,456
| +29% | +$464K | 0.32% | 29 |
|
|
2015
Q2 | $1.58M | Sell |
49,836
-2,817
| -5% | -$91.8K | 0.25% | 28 |
|
|
2015
Q1 | $1.74M | Buy |
52,653
+15,810
| +43% | +$503K | 0.28% | 25 |
|
|
2014
Q4 | $1.09M | Buy |
36,843
+17,918
| +95% | +$514K | 0.16% | 44 |
|
|
2014
Q3 | $531K | Sell |
18,925
-658
| -3% | -$18.5K | 0.08% | 81 |
|
|
2014
Q2 | $551K | Sell |
19,583
-332
| -2% | -$9.46K | 0.07% | 100 |
|
|
2014
Q1 | $607K | Buy |
19,915
+159
| +0.8% | +$4.74K | 0.08% | 94 |
|
|
2013
Q4 | $574K | Buy |
19,756
+95
| +0.5% | +$2.77K | 0.07% | 106 |
|
|
2013
Q3 | $536K | Sell |
19,661
-1,977
| -9% | -$53.8K | 0.08% | 90 |
|
|
2013
Q2 | $575K | Buy |
+21,638
| New | +$598K | 0.09% | 71 |
|
Other funds holding PFE
HighTower Trust's PFE Position: Q1 2023 in Review
HighTower Trust reduced its Pfizer (PFE) stake by 16% in Q1 2023, selling an estimated $770K and leaving 95,301 shares worth $3.75M. The position accounts for 0.37% of the portfolio, ranked #45.
HighTower Trust first reported a position in PFE in Q2 2013 and has held it in 40 quarters since. The position peaked at $9.77M in Q3 2018. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- HighTower Trust held 95,301 shares of Pfizer worth $3.75M as of Q1 2023.
- HighTower Trust sold 17,829 Pfizer shares in Q1 2023, an estimated $770K.
- Pfizer made up 0.37% of HighTower Trust's portfolio in Q1 2023, its #45 holding.
- HighTower Trust first reported a position in Pfizer in Q2 2013 and has held it in 40 quarters since.
- HighTower Trust's Pfizer position peaked at $9.77M in Q3 2018.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.